Annual Drug Patent Expirations for ORLADEYO
Orladeyo is a drug marketed by Biocryst and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has sixty-three patent family members in thirty-two countries.
The generic ingredient in ORLADEYO is berotralstat hydrochloride. One supplier is listed for this compound. Additional details are available on the berotralstat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
